Myeloid and erythroid stem cells: regulation in normal and neoplastic states.
D000818:Animals; D002454:Cell Differentiation; D002455:Cell Division / Q000187:drug effects; D003115:Colony-Stimulating Factors / Q000502:physiology*; D004731:Endotoxins / Q000627:therapeutic use; D004920:Erythropoiesis; D006023:Glycoproteins / Q000494:pharmacology; D006133:Growth Substances / Q000502:physiology; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D007377:Interleukin-3; D007951:Leukemia, Myeloid / Q000503:physiopathology; D015470:Leukemia, Myeloid, Acute / Q000473:pathology* / Q000628:therapy; D008222:Lymphokines / Q000502:physiology; D008407:Mast Cells / Q000502:physiology; D011289:Preleukemia / Q000628:therapy; D012475:Salmonella; D014409:Tumor Necrosis Factor-alpha
D003115:Colony-Stimulating Factors; D004731:Endotoxins; D006023:Glycoproteins; D006133:Growth Substances; D007377:Interleukin-3; D008222:Lymphokines; D014409:Tumor Necrosis Factor-alpha; C044700:novo-pyrexal